Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus

JB Bilsborrow, E Doherty, PV Tilstam… - Expert opinion on …, 2019 - Taylor & Francis
Introduction. Macrophage migration inhibitory factor (MIF) is a pleiotropic inflammatory
cytokine with upstream regulatory roles in innate and adaptive immunity and is implicated in …

Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives

L Pawig, C Klasen, C Weber, J Bernhagen… - Frontiers in …, 2015 - frontiersin.org
CXCR4 and its ligand CXCL12 mediate the homing of progenitor cells in the bone marrow
and their recruitment to sites of injury, as well as affect processes such as cell arrest …

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation

T Lang, JPW Lee, K Elgass, AA Pinar, MD Tate… - Nature …, 2018 - nature.com
Macrophage migration inhibitory factor (MIF) exerts multiple effects on immune cells, as well
as having functions outside the immune system. MIF can promote inflammation through the …

Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities

C O'Reilly, M Doroudian, L Mawhinney… - Medicinal research …, 2016 - Wiley Online Library
Strong evidence has been presented linking chronic inflammation to the onset and
pathogenesis of cancer. The multifunctional pro‐inflammatory protein macrophage migration …

Macrophage migration inhibitory factor (MIF)-based therapeutic concepts in atherosclerosis and inflammation

D Sinitski, C Kontos, C Krammer… - Thrombosis and …, 2019 - thieme-connect.com
Chemokines orchestrate leukocyte recruitment in atherosclerosis and their blockade is a
promising anti-atherosclerotic strategy, but few chemokine-based approaches have …

Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets

S Günther, P Fagone, G Jalce, AG Atanasov… - Drug discovery today, 2019 - Elsevier
Highlights•MIF acts cytokine, enzyme, endocrine hormone and chaperon-like molecule.•D-
DT, a member of the MIF family, exerts non-redundant effects from MIF.•MIF and D-DT are up …

CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

F Borghese, FIL Clanchy - Expert opinion on therapeutic targets, 2011 - Taylor & Francis
Introduction: CD74, also known as the invariant chain, participates in several key processes
of the immune system, including antigen presentation, B-cell differentiation and inflammatory …

[HTML][HTML] OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases

M Thiele, SC Donnelly, RA Mitchell - Journal for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine with a pleiotropic
spectrum of biological functions implicated in the pathogenesis of cancer and inflammatory …

Arrest functions of the MIF ligand/receptor axes in atherogenesis

S Tillmann, J Bernhagen, H Noels - Frontiers in immunology, 2013 - frontiersin.org
Macrophage migration inhibitory factor (MIF) has been defined as an important chemokine-
like function (CLF) chemokine with an essential role in monocyte recruitment and arrest …

MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development

J Bloom, S Sun, Y Al-Abed - Expert opinion on therapeutic targets, 2016 - Taylor & Francis
Introduction: Macrophage migration inhibitory factor (MIF) has emerged as a promising drug
target in diseases including sepsis, rheumatoid arthritis, and cancer. MIF has multiple …